1-1 of 1
Tony Reiman, MD, MSc
Close
Sort by
Journal Articles

Pre-Clinical Validation of Polo-Like Kinase 1 as a Therapeutic Target in Multiple Myeloma with the Selective Inhibitor BI2536.

Roger Sidhu, MD, Tara Steffler, Gail Hipperson, Michelle Jung, Joyce Fung, Linda M. Pilarski, PhD, Andrew R. Belch, MD, Tony Reiman, MD, MSc
Journal: Blood
Blood (2007) 110 (11): 2514.
https://doi.org/10.1182/blood.V110.11.2514.2514
Published: 2007